Skip to content

A Multicenter Randomized Controlled Trial Comparing the Diagnostic Yield of a Multi-Segment Cytology Brush and a Conventional Brush for Malignant Biliary Strictures

A Multicenter Randomized Controlled Trial Comparing the Diagnostic Yield of a Multi-Segment Cytology Brush and a Conventional Brush for Malignant Biliary Strictures - SCRUB Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1040250215
Enrollment
100
Registered
2026-03-25
Start date
2026-03-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biliary Strictures Biliary Strictures, cholangiocarcinoma

Interventions

This study is a multicenter, prospective interventional study (randomized controlled trial) with a crossover design. In each enrolled patient, brush cytology will be performed using both the novel bru
biliary brush cytology, ERCP, biliary stricture, brush catheter

Sponsors

Inoue Tadahisa
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Individuals with biliary stricture identified on imaging findings such as CT, MRI, or ultrasonography. 2. Individuals judged to require pathological diagnosis for the differential diagnosis of cholangiocarcinoma. 3. Individuals aged 18 years or older at the time of informed consent, regardless of sex. 4. Individuals from whom written informed consent has been voluntarily obtained from the participants themselves after they have received a sufficient explanation of the study and have adequately understood its contents.

Exclusion criteria

Exclusion criteria: 1. Patients with an already established pathological diagnosis of the target biliary stricture lesion. 2. Patients in whom pancreatic cancer is suspected based on imaging findings. 3. Patients in whom extrinsic biliary stricture due to compression by lymph nodes or other lesions is suspected based on imaging findings. 4. Patients in whom biliary access by ERCP is impossible or considered difficult. 5. Patients with surgically altered anatomy. 6. Patients judged unable to safely undergo endoscopic examination. 7. Patients who are pregnant or may be pregnant. 8. Patients considered inappropriate for participation in this study by the principal investigator or a subinvestigator.

Design outcomes

Primary

MeasureTime frame
Sensitivity

Secondary

MeasureTime frame
Adequate specimen collection rate Specificity Accuracy Adverse event rate Cellularity

Contacts

Public ContactTadahisa Inoue

Aichi Medical University

tinoue-tag@umin.ac.jp+81-561623311

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026